MUC1 alters β-catenin-dependent tumor formation and promotes cellular invasion
- 5 March 2003
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 22 (9), 1324-1332
- https://doi.org/10.1038/sj.onc.1206291
Abstract
MUC1 is aberrantly expressed in greater than 90% of all breast carcinomas, yet its function as a tumor antigen is not fully understood. Recently, studies have shown that MUC1 interacts with beta-catenin, erbB receptors, src, GSK-3beta and protein kinase Cdelta, possibly in a complex that promotes the disassembly of adherens junctions and the invasion of cells. Here we show that the deletion of Muc1 expression from MMTV-Wnt-1 transgenic mice results in a significant increase in the time to mammary gland tumor onset. Analysis of MMTV-Wnt-1 tumors on a wild-type Muc1 background shows a tumor-specific complex formation between Muc1 and beta-catenin that can be observed in both the membrane and the cytoplasm of transformed epithelium. Analysis of primary human adenocarcinomas revealed that this MUC1/beta-catenin interaction occurs in both primary and metastatic tumors, but is dramatically increased in metastatic lesions. Addition of MUC1-cytoplasmic domain peptides to the invasive MDA-MB-468 and MDA-MB-231 cell lines increases their invasive capability, and these peptides colocalize with both beta-catenin and the focal adhesion protein vinculin, primarily at sites of membrane invasion into a collagen matrix. These data indicate a potential mechanism for MUC1 promotion of invasive tumorigenesis in the breast through the modulation of beta-catenin localization and subsequent cytoskeletal dynamics.This publication has 30 references indexed in Scilit:
- The Epidermal Growth Factor Receptor Regulates Interaction of the Human DF3/MUC1 Carcinoma Antigen with c-Src and β-CateninOnline Journal of Public Health Informatics, 2001
- The c-Src Tyrosine Kinase Regulates Signaling of the Human DF3/MUC1 Carcinoma-associated Antigen with GSK3β and β-CateninOnline Journal of Public Health Informatics, 2001
- β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progressionProceedings of the National Academy of Sciences of the United States of America, 2000
- Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancerOncogene, 2000
- Interaction of Glycogen Synthase Kinase 3β with the DF3/MUC1 Carcinoma-Associated Antigen and β-CateninMolecular and Cellular Biology, 1998
- Characterization of Cell–Matrix Adhesion Requirements for the Formation of Fascin MicrospikesMolecular Biology of the Cell, 1997
- N-Cadherin Promotes Adhesion Between Invasive Breast Cancer Cells and the StromaCell Adhesion and Communication, 1997
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- Is episialin/MUC1 involved in breast cancer progression?Cancer Letters, 1995
- Detection of the tumour‐associated antigens recognized by the monoclonal antibodies hmfg‐1 and 2 in serum from patients with breast cancerInternational Journal of Cancer, 1984